
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (08): 973-978.DOI: 10.12114/j.issn.1007-9572.2021.01.041
Special Issue: 儿科最新文章合辑; 泌尿系统疾病最新文章合辑
• Original Research • Previous Articles Next Articles
Is the Change of Cytokines Related to Renal Damage in Children with IgA Vasculitis?
Department of Pediatrics,Shengjing Hospital of China Medical University,Shenyang 110000,China
*Corresponding author:DU Yue,Professor;E-mail:duy @sj-hospital.org
Received:2021-06-23
Revised:2021-11-14
Published:2022-03-15
Online:2022-03-02
通讯作者:
杜悦
CLC Number:
WANG Mengdi, DU Yue.
Is the Change of Cytokines Related to Renal Damage in Children with IgA Vasculitis? [J]. Chinese General Practice, 2022, 25(08): 973-978.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2021.01.041
| 组别 | 例数 | 性别(男/女) | 年龄〔M(P25,P75),岁〕 |
|---|---|---|---|
| 对照组 | 60 | 28/32 | 8(6,9) |
| IgAV肾损害组 | 97 | 54/43 | 8(6,10) |
| IgAV组 | 97 | 57/40 | 7(6,10) |
| χ2(H)值 | 2.246 | 2.817a | |
| P值 | 0.325 | 0.245 |
Table 1 Comparison of age and sex among IgAV renal damage group,IgAV group,and control group
| 组别 | 例数 | 性别(男/女) | 年龄〔M(P25,P75),岁〕 |
|---|---|---|---|
| 对照组 | 60 | 28/32 | 8(6,9) |
| IgAV肾损害组 | 97 | 54/43 | 8(6,10) |
| IgAV组 | 97 | 57/40 | 7(6,10) |
| χ2(H)值 | 2.246 | 2.817a | |
| P值 | 0.325 | 0.245 |
| 组别 | 例数 | IL-2 | IL-4 | IL-6 | IL-10 | IL-17 | IFN-γ | TNF-α |
|---|---|---|---|---|---|---|---|---|
| 对照组 | 60 | 0.78(0.60,1.02) | 1.39(1.14,1.80) | 2.77(1.84,5.54) | 1.98(1.56,2.30) | 6.97(5.95,9.10) | 1.43(1.17,1.7) | 1.425(1.1,1.88) |
| IgAV肾损害组 | 97 | 0.99(0.71,1.28)a | 1.79(1.38,2.24) | 2.29(1.75,3.89) | 2.07(1.61,2.85) | 10.62(7.47,14.06)a | 1.35(1.09,1.68) | 1.61(1.25,1.98) |
| IgAV组 | 97 | 1.16(0.84,1.50)ab | 1.56(1.22,2.11) | 3.82(2.43,6.58)ab | 2.71(2.08,3.68)ab | 8.97(6.62,10.75)ab | 1.03(0.81,1.32)ab | 1.86(1.45,2.37)ab |
| H值 | 25.759 | 12.517 | 19.941 | 37.234 | 28.236 | 33.495 | 17.363 | |
| P值 | <0.001 | 0.200 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 2 Comparison of cytokines among IgAV renal damage,IgAV,and control groups
| 组别 | 例数 | IL-2 | IL-4 | IL-6 | IL-10 | IL-17 | IFN-γ | TNF-α |
|---|---|---|---|---|---|---|---|---|
| 对照组 | 60 | 0.78(0.60,1.02) | 1.39(1.14,1.80) | 2.77(1.84,5.54) | 1.98(1.56,2.30) | 6.97(5.95,9.10) | 1.43(1.17,1.7) | 1.425(1.1,1.88) |
| IgAV肾损害组 | 97 | 0.99(0.71,1.28)a | 1.79(1.38,2.24) | 2.29(1.75,3.89) | 2.07(1.61,2.85) | 10.62(7.47,14.06)a | 1.35(1.09,1.68) | 1.61(1.25,1.98) |
| IgAV组 | 97 | 1.16(0.84,1.50)ab | 1.56(1.22,2.11) | 3.82(2.43,6.58)ab | 2.71(2.08,3.68)ab | 8.97(6.62,10.75)ab | 1.03(0.81,1.32)ab | 1.86(1.45,2.37)ab |
| H值 | 25.759 | 12.517 | 19.941 | 37.234 | 28.236 | 33.495 | 17.363 | |
| P值 | <0.001 | 0.200 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| 组别 | 例数 | 总T淋巴细胞(%) | Th/Ts | NK〔M(P25,P75),%〕 | 总B淋巴细胞〔M(P25,P75),%〕 | 总T绝对数〔M(P25,P75)〕 | NK总数〔M(P25,P75)〕 | 总B淋巴细胞计数〔M(P25,P75)〕 | IgA〔M(P25,P75),g/L〕 | IgE 〔M(P25,P75),g/L〕 |
|---|---|---|---|---|---|---|---|---|---|---|
| IgAV肾损害组 | 97 | 63.6±10.2 | 1.07(0.78,1.32) | 11.30(7.90,18.00) | 21.10(16.19,26.60) | 1 262(843,1 762) | 228(138,362) | 371(260,609) | 2.60(1.93,3.28) | 82.85(29.59,173.50) |
| IgAV组 | 97 | 59.4±9.3 | 0.97(0.81,1.30) | 12.45(8.10,18.97) | 25.55(19.53,31.10) | 1 156(724,1 420) | 209(156,333) | 453(324,618) | 2.05(1.53,2.74) | 66.55(32.89,180.00) |
| u(t)值 | 3.030a | -0.453 | -0.803 | -3.375 | -1.917 | -0.254 | -1.260 | -2.618 | -0.022 | |
| P值 | 0.003 | 0.651 | 0.422 | 0.001 | 0.055 | 0.799 | 0.208 | 0.009 | 0.972 |
Table 3 Comparison of absolute counts of IgA,IgE,and lymphocytes between IgAV renal damage and IgAV groups
| 组别 | 例数 | 总T淋巴细胞(%) | Th/Ts | NK〔M(P25,P75),%〕 | 总B淋巴细胞〔M(P25,P75),%〕 | 总T绝对数〔M(P25,P75)〕 | NK总数〔M(P25,P75)〕 | 总B淋巴细胞计数〔M(P25,P75)〕 | IgA〔M(P25,P75),g/L〕 | IgE 〔M(P25,P75),g/L〕 |
|---|---|---|---|---|---|---|---|---|---|---|
| IgAV肾损害组 | 97 | 63.6±10.2 | 1.07(0.78,1.32) | 11.30(7.90,18.00) | 21.10(16.19,26.60) | 1 262(843,1 762) | 228(138,362) | 371(260,609) | 2.60(1.93,3.28) | 82.85(29.59,173.50) |
| IgAV组 | 97 | 59.4±9.3 | 0.97(0.81,1.30) | 12.45(8.10,18.97) | 25.55(19.53,31.10) | 1 156(724,1 420) | 209(156,333) | 453(324,618) | 2.05(1.53,2.74) | 66.55(32.89,180.00) |
| u(t)值 | 3.030a | -0.453 | -0.803 | -3.375 | -1.917 | -0.254 | -1.260 | -2.618 | -0.022 | |
| P值 | 0.003 | 0.651 | 0.422 | 0.001 | 0.055 | 0.799 | 0.208 | 0.009 | 0.972 |
| 变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 总T淋巴细胞 | -0.023 | 0.023 | 0.991 | 0.059 | 1.164 | (1.001,1.354) |
| 总B淋巴细胞 | 0.026 | 0.025 | 1.016 | 0.135 | 1.042 | (0.987,1.100) |
| IgA | -0.206 | 0.164 | 1.581 | 0.150 | 0.781 | (0.558,1.093) |
| IL-2 | 0.934 | 0.391 | 5.695 | 0.018 | 2.715 | (1.186,6.214) |
| IL-6 | 0.052 | 0.039 | 1.806 | 0.142 | 1.062 | (0.980,1.152) |
| IL-10 | -0.015 | 0.110 | 0.019 | 0.533 | 0.928 | (0.735,1.173) |
| IL-17 | -0.105 | 0.040 | 6.720 | 0.015 | 0.904 | (0.833,0.981) |
| IFN-γ | -1.712 | 0.428 | 16.004 | <0.001 | 0.163 | (0.065,0.404) |
| TNF-α | 0.524 | 0.291 | 3.249 | 0.036 | 1.892 | (1.042,3.434) |
Table 4 Multivariate Logistic regression analysis of factors influencing renal damage in children with IgAV
| 变量 | β | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 总T淋巴细胞 | -0.023 | 0.023 | 0.991 | 0.059 | 1.164 | (1.001,1.354) |
| 总B淋巴细胞 | 0.026 | 0.025 | 1.016 | 0.135 | 1.042 | (0.987,1.100) |
| IgA | -0.206 | 0.164 | 1.581 | 0.150 | 0.781 | (0.558,1.093) |
| IL-2 | 0.934 | 0.391 | 5.695 | 0.018 | 2.715 | (1.186,6.214) |
| IL-6 | 0.052 | 0.039 | 1.806 | 0.142 | 1.062 | (0.980,1.152) |
| IL-10 | -0.015 | 0.110 | 0.019 | 0.533 | 0.928 | (0.735,1.173) |
| IL-17 | -0.105 | 0.040 | 6.720 | 0.015 | 0.904 | (0.833,0.981) |
| IFN-γ | -1.712 | 0.428 | 16.004 | <0.001 | 0.163 | (0.065,0.404) |
| TNF-α | 0.524 | 0.291 | 3.249 | 0.036 | 1.892 | (1.042,3.434) |
| [1] | JENNETTE J C, FALK R J, BACON P A,et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum,2013,65(1):1-11. DOI:10.1002/art.37715. |
| [2] | SHI D, CHAN H, YANG X,et al. Risk factors associated with IgA vasculitis with nephritis (Henoch-Schönlein Purpura nephritis) progressing to unfavorable outcomes:a meta-analysis[J]. PLoS One,2019,14(10):e0223218. DOI:10.1371/journal.pone.0223218. |
| [3] | LI Y Y, LI C R, WANG G B,et al. Investigation of the change in CD4+ T cell subset in children with Henoch-Schonlein Purpura[J]. Rheumatol Int,2012,32(12):3785-3792. DOI:10.1007/s00296-011-2266-3. |
| [4] | OZEN S. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides[J]. Ann Rheum Dis,2005,65(7):936-941. DOI:10.1136/ard.2005.046300. |
| [5] | 中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志,2017,55(9):647-651. |
| [6] | 杨思睿,刘德滢,王晶华,等. IgA血管炎的免疫机制和治疗现状及展望[J].中华实用儿科临床杂志,2016,31(9):641-645.DOI:10.3760/cma.j.issn.2095-428X.2016.09.001. |
| [7] | 孙莹莹,刘霞,黄岩杰. 辅助T淋巴细胞17及白细胞介素-17在过敏性紫癜及紫癜性肾炎发病中的作用[J]. 现代中西医结合杂志,2016,25(5):567-570. DOI:10.3969/j.issn.1008-8849.2016.05.040. |
| [8] | DOLFF S, WITZKE O, WILDE B. Th17 cells in renal inflammation and autoimmunity[J]. Autoimmun Rev,2019,18(2):129-136. DOI:10.1016/j.autrev.2018.08.006. |
| [9] | TURNER J E, PAUST H J, STEINMETZ O M,et al. The Th17 immune response in renal inflammation[J]. Kidney Int,2010,77(12):1070-1075. DOI:10.1038/ki.2010.102. |
| [10] | SCHMIDT T, LUEBBE J, PAUST H J,et al. Mechanisms and functions of IL-17 signaling in renal autoimmune diseases[J]. Mol Immunol,2018,104:90-99. DOI:10.1016/j.molimm.2018.09.005. |
| [11] | 陈敏广,林瑞霞,杨青,等. 儿童过敏性紫癜肾炎血清中IFN-γ水平及临床意义[J]. 中国中西医结合肾病杂志,2005,6(11):659-660. |
| [12] | RICE E K, NIKOLIC-PATERSON D J, HILL P A,et al. Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells[J]. Nephrology,2003,8(3):156-161. DOI:10.1046/j.1440-1797.2003.00152.x. |
| [13] | LU H, BAI Y Y, WU L F,et al. Inhibition of macrophage migration inhibitory factor protects against inflammation and matrix deposition in kidney tissues after injury[J]. Mediat Inflamm,2016,2016:1-12. DOI:10.1155/2016/2174682. |
| [14] | GÜLHAN B, ORHAN D, KALE G,et al. Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein Purpura)[J]. Pediatr Nephrol,2015,30(8):1269-1277. DOI:10.1007/s00467-015-3051-4. |
| [15] | KAPLANSKY G, BONGRAND P. Cytokines and chemokines[J]. Cell Mol Biol (Noisy-le-grand),2001,47(4):569-574. |
| [16] | ZHANG H F, LIANG G B, ZHAO M G,et al. Regulatory T cells demonstrate significantly increased functions following stimulation with IL-2 in a Tim-3-dependent manner in intracranial aneurysms[J]. Int Immunopharmacol,2018,65:342-347. DOI:10.1016/j.intimp.2018.10.029. |
| [17] | KAWASAKI Y, SUZUKI J, SAKAI N,et al. Evaluation of T helper-1/-2 balance on the basis of IgG subclasses and serum cytokines in children with glomerulonephritis[J]. Am J Kidney Dis,2004,44(1):42-49. DOI:10.1053/j.ajkd.2004.03.029. |
| [18] | 江华,丁甫月,顾龙君. 过敏性紫癜患儿血清IFN-α、IL-2、IL-4、TNF-α水平的变化[J]. 中国当代儿科杂志,2002,4(2):117-118. |
| [19] | LI M M, LIU N, ZHAGN M,et al. Clinical significance of serum midkine in children with henoch-schonlein Purpura[J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi,2017,25(1):181-185. DOI:10.7534/j.issn.1009-2137.2017.01.032. |
| [20] | MALEK T R. The main function of IL-2 is to promote the development of T regulatory cells[J]. J Leukoc Biol,2003,74(6):961-965. DOI:10.1189/jlb.0603272. |
| [21] | 潘凯丽,白庆峰,黄莹,等. 过敏性紫癜患儿血清白细胞介素-4、-6、-8及肿瘤坏死因子-α表达的意义[J]. 实用儿科临床杂志,2007,22(21):1632-1633. |
| [22] | 翁小斌,鲍金芳. 过敏性紫癜患儿血清IL-6、IL-12、TFN-α水平变化及临床意义[J]. 浙江医学,2014,36(9):791-792. |
| [23] | MAKITA Y, SUZUKI H, KANO T,et al. TLR9 activation induces aberrant IgA glycosylation via APRIL-and IL-6-mediated pathways in IgA nephropathy[J]. Kidney Int,2020,97(2):340-349. DOI:10.1016/j.kint.2019.08.022. |
| [24] | 金丽威.白介素10家族研究近况[J].国外医学(免疫学分册),2005,28(4):246-249. |
| [25] | WU H T, WEN Y B, YUE C,et al. Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin a vasculitis nephritis[J]. Dis Markers,2020,2020:1-7. DOI:10.1155/2020/5514145. |
| [1] | ZENG Ling, XIE Leyun, YU Renhe, SONG Lin, ZENG Saizhen. Age-stratified Clinical Characteristics and Risk Factors for Lobar Pneumonia in Children with Mycoplasma Pneumoniae Pneumonia [J]. Chinese General Practice, 2026, 29(32): 4752-4758. |
| [2] | SU Die, ZHANG Yan, CHEN Xiaosong, HAN Yuxia, YAN Yongbin, DUAN Junya, CHEN Xinying, ZHAO Chenghao. Outcome Measures in Randomized Controlled Trials of Traditional Chinese Medicine for Refractory Mycoplasma Pneumoniae Pneumonia in Children [J]. Chinese General Practice, 2026, 29(31): 4609-4618. |
| [3] | ZHANG Xiaozhen, YANG Chengbo, JIN Qianhui, WANG Shuai, ZHOU Jihe. Comparative Study on the Effects of the Computer Assisted Rehabilitation Environment System and Conventional Rehabilitation on Improving Motor Function in Children with Global Developmental Delay [J]. Chinese General Practice, 2026, 29(27): 3938-3946. |
| [4] | Expert Group on Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China, Professional Committee on Obesity Control in Women and Children, China Maternal and Child Health Research Association. Guidelines for the Assessment, Treatment, and Prevention of Childhood Obesity in China (Second Edition) [J]. Chinese General Practice, 2026, 29(23): 3233-3252. |
| [5] | GAO Min, DING Ying, HAN Shanshan, XU Yan, WU Ruihong, LI Yudi. Correlation of Selected Blood Biomarkers with 24-hour Urine Protein Excretion in 3 774 Pediatric Patients with IgA Vasculitis Nephritis [J]. Chinese General Practice, 2026, 29(23): 3320-3328. |
| [6] | MA Linling, WANG Qiqiong, NI Xiaofeng, SHI Yuqing, WEN Yan, PAN Xiangcheng. Construction of a Scientific Popularization Framework for Antibacterial Drugs for Children Discharged from Hospital [J]. Chinese General Practice, 2026, 29(22): 3214-3219. |
| [7] | ZHANG Ji, LI Ling, ZHOU Jie, WU Yanli, JI Wei, LIU Tao. A Prospective Cohort Study on Relationship between Lipid Accumulation Product and Incidence of Metabolic Syndrome in Adults [J]. Chinese General Practice, 2026, 29(22): 3138-3145. |
| [8] | CHAI Zhihao, ZHANG Weisen, LUO Jiaoling, ZHU Feng, ZHU Tong, JIN Yali, PAN Jing, LU Yingjun, JIANG Chaoqiang. The Mediation Effect of Socioeconomic Status in Childhood Parental Literacy and Cognitive Function in Middle-aged and Older People: Based on Guangzhou Biobank Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2959-2966. |
| [9] | HUANG Haili, LI Yuhong, YU Yang, GUO Ping, HAN Changzheng, LIU Ping. A Mixed Study of Fertility Intention and Its Influencing Factors among the Childbearing-age Women in Anhui Province [J]. Chinese General Practice, 2026, 29(20): 2887-2894. |
| [10] | XIONG Xiaoman, LI Aijun, ZHENG Yuehong, YANG Qiuyan, ZHANG Yanli. To Explore the Necessity of Bronchodilation Test in Children with Normal FEV1, FVC and FEV1/FVC but Decreased Small Airway Function [J]. Chinese General Practice, 2026, 29(15): 1992-1997. |
| [11] | LIU Xiaoyu, ZHU Rongxin, ZHANG Bo, SU Hang, REN Xianqing. Defining Clinical Questions and Outcome Indicators in Guidelines for Diagnosis and Treatment of Nocturnal Enuresis in Children with Integrated Traditional Chinese and Western Medicine Based on Modified Delphi Method [J]. Chinese General Practice, 2026, 29(15): 2050-2055. |
| [12] | SHEN Yong, ZHOU Jingying, WANG Xueping, JIA Meixiang, LIU Jiajia, ZHAN Haojian, WANG Lifang, YAN Hao, PENG Danyuan, YUE Weihua. Construction of Support Services List for Parents of Children with Autism Based on "Timing It Right" Theory [J]. Chinese General Practice, 2026, 29(13): 1688-1698. |
| [13] | YAN Beibei, XU Huaifu. Children's Type 1 Diabetes-specific Self-reported Outcomes Scales: Measurement Properties Evaluation Based on COSMIN Guidelines [J]. Chinese General Practice, 2026, 29(12): 1624-1632. |
| [14] | LIU Xiang, CHEN Hong, CUI Rui, GUO Zhichao, LI Panpan, CAO Zilong, JI Yiqing, YU Wenya. Consistencies and Differences in Early Childhood Development Characteristics in Megacities: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(11): 1411-1421. |
| [15] | YANG Jingran, MA Fang, WANG Yu, ZHANG Yimei, ZHOU Min. Summary of Best Evidence for Pain Management after Open-heart Surgery in Children with Congenital Heart Disease [J]. Chinese General Practice, 2026, 29(11): 1473-1480. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||